Xcout Intel
Spot Biosystems competitors & alternatives
The 12 closest competitors and alternatives to Spot Biosystems among healthcare companies — ranked by similarity to what Spot Biosystems actually does, not by market-cap band.
Subscribe to see Spot Biosystems’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Spot Biosystems
Spot Biosystems is a gene therapy company pioneering a novel non-viral extracellular delivery approach. Headquartered in Palo Alto, California, the company launched with significant financing to advance its therapeutic pipeline.
Spot Biosystems at a glance
Spot Biosystems is a healthcare company headquartered in United States. Its most recent funding round, Series A, raised $40M in June 2026. Xcout tracks 1 named person at Spot Biosystems, including Andrew Lee (Co-Founder).
Spot Biosystems leadership
- Andrew LeeCo-Founder
Spot Biosystems funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Spot Biosystems competitors
Ranked by semantic similarity — how close each company is to Spot Biosystems by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
GenEdit is a South San Francisco, California-based startup developing alternative methods of delivering gene-based and CRISPR-based medicines.
Similar healthcare company
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Similar healthcare company
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
Biotechnology
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Life Science
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Biotechnology
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Biotechnology
Eyevensys is a biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its platform uses electro-transfection of the eye’s ciliary muscle to enable sustained local production of therapeutic proteins for retinal and other ocular conditions.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Biotech
SonoThera, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on developing genetic medicines and advancing the field of gene therapy.
Healthcare & Life Sciences
ViaNautis Bio Ltd. is a groundbreaking nanomedicine company headquartered in Cambridge, UK, at the forefront of genetic therapies. The company leverages its proprietary polyNaut platform to develop novel products for delivering genetic medicines.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Spot Biosystems and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Spot Biosystemsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →